GREY:LXXGQ - Post by User
Post by
Chopper1BigDogon Mar 01, 2021 8:48am
167 Views
Post# 32683983
Lex
Lex Reminder of just how big Lexagene will be! LexaGene’s MiQLab™ system is designed to respond to multi-billion dollar markets in need of rapid automated pathogen detection and customized testing.
Human Clinical Diagnostics
• COVID-19 testing $5.2 Billion USD market
• Rapid qPCR testing needed
• PCR testing considered the gold-standard of testing
• $12.9 billion USD by 2025
> Learn more
Veterinary Diagnostics
• Companion animal diagnostics
• Infections and antibiotic resistance can be quickly detected so the appropriate antibiotic is prescribed
• Reference laboratory accounts for largest market share of the veterinary diagnostics market
• North America accounts for largest segment due to well-established animal healthcare market
• $2.2 billion USD Market by 2024
> Learn more
Food Safety Testing
• 1.1 B tests performed per year
• Mandatory food testing now required
• Prevents costly recalls, brand damage
• Fresher, safer product to customer (eliminates 2-day hold on food)
• Hundreds of food recalls in the US each year
• Major disease-causing pathogen: Salmonella/E. coli
• $23.4 Billion USD market by 2024
> Learn more
Open-Access Markets
$20 Billion USD markets:
• Labs looking for automation and customization
• Pharma, biotech, academic labs – (18,000 moderate complexity CLIA labs in the US)
• PCR market – $4.33B USD by 2026
• Genotyping – $11.8B USD
Other open-access markets:
• Water Quality Monitoring – $1.59B USD by 2022
• Agricultural Testing – $6.29B USD by 2022
• Aquaculture Bacterial Testing
> Learn more
Pandemic Prevention
Threat of next outbreak or pandemic is real
• LexaGene technology ideally suited to contain outbreaks
• Need rapid time to results for quarantine decisions
• Test at point-of-need required (hospitals, clinics, institutions)
• Need tests that can be easily deployed
• Require reagents that are easy to manufacture for worldwide coverage
• Current testing methods don’t meet the needs
More Markets
LexaGene’s technology has a wide range of applications across other markets at point-of-need:
• Cruise ships
• Biodefense
• Military bases and aircraft carriers
• Etc.